Delivery Order SPE2DB22D2206-SPE2DB24FDU83
Award Date 10/20/23
Potential Completion Date 11/13/23
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,553.93 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 140 mg capsules (90-count) under a firm fixed-price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by November 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $7,845.72 to supply 90 capsules of IMBRUVICA 140 MG per capsule. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by December 4, 2023. No set-aside designation was applied to this order, which was awarded against an indefinite-delivery contract held by Amerisourcebergen to provide...
- The Defense Logistics Agency Troop Support Medical awarded a $31,382.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of the pharmaceutical IMBRUVICA 140 MG. Performance will take place in Conshohocken, Pennsylvania under a period of performance spanning September 26, 2023 through October 18, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order for the prescription medication to support the Defense Logistics Agency's...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $20,921.90 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 120 capsules of IMBRUVICA 140 MG CAPSULE. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies to be delivered by January 4, 2024. No set-aside designation was applied to this order, which was awarded against an existing indefinite delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $47,074.32 to Amerisourcebergen Drug Corporation for the supply of IMBRUVICA 140 MG capsules. Under the contract, Amerisourcebergen will deliver 90 capsules of IMBRUVICA to a facility located in Conshohocken, Pennsylvania, with performance spanning from September 28 to October 20 of this year. As the prime contractor, Amerisourcebergen will utilize its corporate office and distribution division based in Conshohocken...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for IMBRUVICA 140 mg capsules (120-count) with a ceiling value of $11,135.23 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on March 3, 2026. No set-aside was used in this award.</p>
- The Defense Logistics Agency awarded a $39,228.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 140 mg Imbruvica capsules. Under this order, Amerisourcebergen will deliver 90 capsules of Imbruvica to a facility in Conshohocken, Pennsylvania by September 28, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will fulfill this order to support the DLA's stocking of prescription drugs for...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 4, 2026, for IMBRUVICA 140 mg capsules (90-count), with a ceiling value of $8,351.42. Place of performance is Conshohocken, PA, with an ultimate completion date of February 26, 2026. The order carries firm fixed pricing and was awarded without set-aside.</p>
- The Defense Logistics Agency awarded a delivery order valued at $11,405.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (120-count units) on November 28, 2025. This is a firm fixed price, non-set-aside contract with a completion date of December 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,553.93 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a completion deadline of December 9, 2025. This firm fixed-price contract, awarded without set-aside designation, reflects a competitive procurement executed under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The award is issued to the contractor's corporate office located in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FDU83Delivery Order
The Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 120 capsules of IMBRUVICA 140 MG CAPSULE for a potential value of ten thousand four hundred sixty dollars and ninety-five cents ($10,460.95). The place of performance will be in Conshohocken, Pennsylvania and all items are to be delivered by November 13, 2023. No set-aside provisions were applied to this firm fixed price order to supply pharmaceutical products for DLA programs.
Generated 1/19/24, 10:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 10/20/23 |